Related Experiment Video
Updated: Aug 14, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Nicotine enhances the circulatory effects of adenosine in human beings
P Smits1, A Eijsbouts, T Thien
1Department of Medicine, University of Nijmegen, The Netherlands.
Abstract:
A randomized, double-blind, and placebo-controlled study was performed in 10 healthy volunteers to evaluate a possible interaction between adenosine and nicotine in human beings. The infusion of adenosine alone (0.07 mg/kg/min) induced an increase in heart rate of 4.7 beats/min versus 0.2 beats/min after placebo administration (p less than 0.02). The infusion of adenosine alone induced a decrease in finger skin temperature compared with placebo administration (-1.0 degrees versus 0.0 degrees C, p less than 0.01). When compared with baseline values, nicotine gum chewing increased systolic and diastolic blood pressures by 6.2 and 7.0 mm Hg, respectively (p less than 0.001), heart rate by 5.5 beats/min (p less than 0.01), and plasma adrenaline levels by 0.03 nmol/L (p less than 0.025), whereas skin temperatures fell by 1.3 degrees C (p less than 0.001). The nicotine-induced increase in heart rate was larger during adenosine infusion than during placebo administration (14.9 versus 5.5 beats/min, p less than 0.001), whereas the increment of diastolic blood pressure was lower (1.1 versus 4.0 mm Hg, p less than 0.05). The increment in systolic blood pressure was not altered by concomitant adenosine infusion. The rise in plasma noradrenaline levels during the combined administration of nicotine and adenosine differed significantly from the response to nicotine alone (+ 0.23 versus -0.05 nmol/L, p less than 0.02). We concluded that, in human beings, the characteristic hemodynamic response to adenosine infusion is enhanced by nicotine.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
CNS Depressants: Alcohol and Nicotine

